American Journal of Bioethics 15 (12):25-29 (2015)
AbstractCRISPR germline editing therapies hold unprecedented potential to eradicate hereditary disorders. However, the prospect of altering the human germline has sparked a debate over the safety, efficacy, and morality of CGETs, triggering a funding moratorium by the NIH. There is an urgent need for practical paths for the evaluation of these capabilities. We propose a model regulatory framework for CGET research, clinical development, and distribution. Our model takes advantage of existing legal and regulatory institutions but adds elevated scrutiny at each stage of CGET development to accommodate the unique technical and ethical challenges posed by germline editing
Added to PP
Historical graph of downloads
Similar books and articles
Human Genome Editing and Ethical Considerations.Kewal Krishan, Tanuj Kanchan & Bahadur Singh - 2016 - Science and Engineering Ethics 22 (2):597-599.
CRISPR Critters and CRISPR Cracks.R. Alta Charo & Henry T. Greely - 2015 - American Journal of Bioethics 15 (12):11-17.
CRISPR/Cas9 and Germline Modification: New Difficulties in Obtaining Informed Consent.Joanna Smolenski - 2015 - American Journal of Bioethics 15 (12):35-37.
In Genes We Trust: Germline Engineering, Eugenics, and the Future of the Human Genome.Russell Powell - 2015 - Journal of Medicine and Philosophy 40 (6):669-695.
"Playing God" and Germline Intervention.Ted Peters - 1995 - Journal of Medicine and Philosophy 20 (4):365-386.
Germline Manipulation and Our Future Worlds.John Harris - 2015 - American Journal of Bioethics 15 (12):30-34.
Three Christian Arguments Against Germline Engineering.R. DiSilvestro - 2012 - Christian Bioethics 18 (2):201-218.
Shaping Individuality: Human Inheritable Germ Line Gene Modification.Maurizio Salvi - 2001 - Theoretical Medicine and Bioethics 22 (6):527-542.
Reproductive and Therapeutic Cloning, Germline Therapy, and Purchase of Gametes and Embryos: Comments on Canadian Legislation Governing Reproduction Technologies.L. Bernier - 2004 - Journal of Medical Ethics 30 (6):527-532.
A Human Germline Modification Scale.Harry Adams - 2004 - Journal of Law, Medicine and Ethics 32 (1):164-173.
Human Germline Genetic Modification – A Utilitarian Bioethical Perspective.Kevin Smith - 2004 - International Journal of Ethics 4 (2).
Human Germline Modification—A Missing Link.Gabriele Werner-Felmayer & Carmel Shalev - 2015 - American Journal of Bioethics 15 (12):49-51.
Human Germline Manipulation: Technical Limits and Future Perspectives.Giovanni Levi - 2001 - Etica E Politica 3 (1).
Editing the Genome of the Human Germline: May Cool Heads Prevail.Eli Y. Adashi & I. Glenn Cohen - 2015 - American Journal of Bioethics 15 (12):40-42.
References found in this work
Germ-Line Gene Therapy and the Medical Imperative.Ronald Munson & Lawrence H. Davis - 1992 - Kennedy Institute of Ethics Journal 2 (2):137-158.
Citations of this work
Intergenerational Monitoring in Clinical Trials of Germline Gene Editing.Bryan Cwik - 2020 - Journal of Medical Ethics 46 (3):183-187.
The Ethics of Gene Editing From an Islamic Perspective: A Focus on the Recent Gene Editing of the Chinese Twins.Qosay A. E. Al-Balas, Rana Dajani & Wael K. Al-Delaimy - 2020 - Science and Engineering Ethics 26 (3):1851-1860.
Germline Genome Editing and the Functions of Consent.Robert Ranisch - 2017 - American Journal of Bioethics 17 (12):27-29.
Modification of the Embryo's Genome: More Useful in Research Than in the Clinic.Heidi Mertes & Guido Pennings - 2015 - American Journal of Bioethics 15 (12):52-53.
A Defense of Limited Regulation of Human Genetic Therapies.James J. Hughes - 2019 - Cambridge Quarterly of Healthcare Ethics 28 (1):112-120.